Navigation Links
Data Presented at Two Global Medical Congresses Reinforce Benefit of Enbrel® (etanercept) for Patients with Chronic Inflammatory Conditions
Date:5/25/2011

ESTA TrialPatients who have PsO and PsA with axial disease (disease involvement in the spine) have a higher burden of disease than those without axial disease (patients who have disease in the peripheral joints only). Data from an exploratory analysis of the PRESTA trial examining patients with moderate-to-severe PsO and PsA found that patients presenting with and without axial disease showed benefit from treatment with ENBREL compared with baseline.

PsoriasisEffects of Etanercept on Cardiometabolic Biomarkers in Subjects with Moderate-to-Severe Plaque Psoriasis: The PRISTINE Trial Psoriasis patients may have an increased incidence of co-morbid conditions, such as diabetes and cardiovascular disease. Data from this exploratory endpoint from the PRISTINE trial studying patients with moderate-to-severe plaque psoriasis found at week 12, ENBREL 50mg once or twice weekly did not negatively impact various biomarkers of cardiometabolic disease like apolipoprotein B/apolipoprotein A1 ratio, hsCRP, and NT-proBNP. The clinical significance of these findings needs to be studied further, but the results are important for consideration as the medical community continues to explore the potentially broader effects of inflammatory disease in the body.

About Rheumatoid ArthritisRheumatoid arthritis affects approximately 0.6 to 0.9 percent of the adult population worldwide and can start at any age, but usually occurs between 40 and 70 years. RA can cause pain, stiffness, swelling and limitation in the motion and function of multiple joints.  In RA, joint damage can significantly worsen over time, especially if left untreated. Joint damage may impair function, and potentially disable some patients.

About PsoriasisPsoriasis affects approximately 7.5 million American adults and is a chronic disease of the immune system that causes the skin cells to grow at an accelerated rate. Although there are several types of psoriasis, approximately 80 percent
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
2. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
3. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
4. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
5. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
6. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
7. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
8. Promising Data from Paratek Pharmaceuticals MAR Inhibitor Program Presented in Late Breaker Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
9. New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis
10. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
11. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/tzzq39/investigation ) ... on China,s Trastuzumab Market, 2010-2019" report to their ... by FDA to be used in the clinic in ... major product of Roche. In 2013, the sales value ... After entering China in ...
(Date:9/3/2015)... DUBLIN , Sept. 3, 2015 Research ... of the "Radiology Information Systems Market by Type, ... Trends & Forecast to 2019" report to their ... market is estimated at $501.1 Million 2014, and is ... CAGR of 7.6% from 2014 to 2019. ...
(Date:9/3/2015)...  The findings of a year-long investigation conducted by ... company,s handling of its Recovery IVC filter product ... , part one of the series revealed ... 27 fatalities, have been associated with the Recovery device. ... C.R. Bard in 2004 which linked the Recovery IVC ...
Breaking Medicine Technology:Investigation Report on China's Trastuzumab (Genentech) Market, 2010-2019 2Radiology Information Systems Market Report 2015 - Global Trends & Forecast to 2019 for the $700+ Million Industry 2Radiology Information Systems Market Report 2015 - Global Trends & Forecast to 2019 for the $700+ Million Industry 3IVC Filter Lawsuit News: NBC News Investigation into C.R. Bard Recovery Filters Raises Disturbing Questions, Bernstein Liebhard LLP Reports 2IVC Filter Lawsuit News: NBC News Investigation into C.R. Bard Recovery Filters Raises Disturbing Questions, Bernstein Liebhard LLP Reports 3
(Date:9/3/2015)... ... September 03, 2015 , ... Real Time Pain Relief (RTPR), ... bull rider David Mason has signed an official endorsement deal with the company. Originally ... six and his first bull at 15. He is an Australian bull riding champion, ...
(Date:9/3/2015)... GA (PRWEB) , ... September 03, 2015 , ... ... cover the cost of graduated compression garments. However, graduated compression garments are an ... Wound care and lymphedema specialist, Robyn Bjork, was recently sponsored by SIGVARIS ...
(Date:9/3/2015)... ... September 03, 2015 , ... The first part of a two-part ... by IVC filter lawsuits filed against Bard.** These lawsuits, filed by persons ... IVC filter broke or failed, have recently been consolidated for pretrial proceedings as multidistrict ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... provider of comprehensive eating disorder treatment for adults and adolescents struggling with ... Calinoiu, MD has joined the medical treatment team. As a Staff Psychiatrist, ...
(Date:9/3/2015)... ... September 03, 2015 , ... Global Vision , the ... will be spotlighting its award-winning print and artwork inspection solutions, ScanProof and ... and 17 at the Olympia London, booth #F33 , Be the first to get ...
Breaking Medicine News(10 mins):Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 2Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 3Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 2Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 3Health News:Bard IVC Lawsuit Allegations Reach National Prime Time News 2Health News:Bard IVC Lawsuit Allegations Reach National Prime Time News 3Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 2Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 3Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 2Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 3
... growing demand for user safety and cost effective solutions. Special purpose ... 2015. , ... San Jose, California (PRWEB) October 27, ... disposable needles, and related products has expanded considerably due to increasing ...
... regarded solely as disease agents -- now are being ... of these so-called oncolytic viruses stem from their potential ... discovered a way of controlling the viruses behind potential ... using microRNAs to restrict them to specific tissues. The ...
... NurseTesting Consulting Service is quickly becoming the nation’s leader ... early in 2008 and has already achieved six Joint Commission ... NurseTessting Consulting Service assures agencies understand and meet the healthcare ... ...
... cooling body, checking arteries lowers risk of further injury , , ... again is only the first step in saving a life ... An advisory, published in the Oct. 23 issue of ... after resuscitation or risk the losing the patient to the ...
... of visitors to Internet drug outlets nearly tripling in ... than ever. Based on its,assessment of more than 1,000 ... Boards of Pharmacy(R) (NABP(R)) finds,that 97% of these sites ... federal laws or established patient safety and pharmacy practice,standards. ...
... Comprehensive Cancer,Center announced that Judy and Larry Freeman ... USC/Norris Comprehensive Cancer Center, Keck School of,Medicine of ... Larry Freeman Cancer,Day Hospital, an outpatient facility currently ... Hospital. Larry Freeman is the founder of Freeman,Cosmetics ...
Cached Medicine News:Health News:Special Purpose Needles Market to Reach $3.7 Billion by 2015, According to New Report by Global Industry Analysts, Inc 2Health News:Special Purpose Needles Market to Reach $3.7 Billion by 2015, According to New Report by Global Industry Analysts, Inc 3Health News:MicroRNAs make for safer cancer treatments 2Health News:New Joint Commission Consulting Service by NurseTesting Grows Fast as Staffing Agencies Seek Joint Commission Certification 2Health News:New Joint Commission Consulting Service by NurseTesting Grows Fast as Staffing Agencies Seek Joint Commission Certification 3Health News:Speedy Care After Heart Attack Key to Survival 2Health News:NABP Findings Underscore Dangers of Purchasing Prescription Medicine Online and From Foreign Sources 2Health News:NABP Findings Underscore Dangers of Purchasing Prescription Medicine Online and From Foreign Sources 3Health News:USC Cancer Center Announces Contribution By Larry and Judy Freeman 2
1.0% Casein digest (NZ amine), 0.5% Sodium Chloride, 0.5% Yeast Extract, 1.0% bacto casamino acids, 0.2% Mag. Sulfate....
0.5% Yeast Extract, 2.0% Tryp, 10mM Sodium Chloride, 2.5mM Potassium Chloride....
SOC Kit for Bacterial Cells containing 10 x 5mls Sterile growth medium with instructions...
Innovative hemi device combining anatomic design with the advanced material pyrocarbon....
Medicine Products: